Author

K. Serizawa

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

F. Shimizu· 1 shared H. Tomizawa-Shinohara· 1 shared J. Nemoto· 1 shared K. Matsuo· 1 shared M. Fujisawa· 1 shared R. M. Ransohoff· 1 shared S. Fujikawa· 1 shared S. Miyake· 1 shared

Activity by Year

2021-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

F. Shimizu

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

IL-6 blockade suppresses the blood-brain barrier disorder, leading to prevention of onset of NMOSD

Y. Takeshita, S. Fujikawa, K. Serizawa, M. Fujisawa, K. Matsuo, J. Nemoto, F. Shimizu, Y. Sano, H. Tomizawa-Shinohara, S. Miyake, R. M. Ransohoff, T. Kanda

The paper shows that IL-6 blockade with satralizumab prevents BBB disruption and lymphocyte migration induced by NMO-IgG in EAE and in vitro BBB models.

bioRxiv · Jan 28, 2021 · PreprintImmunology